Role of Endoscopy in Familial Adenomatous Polyposis Syndromes
Publication Date: March 10, 2020
Recommendations
We recommend genetic counseling and testing in patients with clinical polyposis defined as 10 or more adenomas found on a single endoscopy and 20 or more adenomas during their lifetime. (L)
324190
We recommend genetic counseling and testing in all first-degree relatives of confirmed polyposis syndrome patients. Suspected FAP individuals should be tested at ages 10 to 12 years, whereas suspected AFAP and MAP should be tested at ages 18 to 20 years. (L)
324190
We recommend screening sigmoidoscopy or colonoscopy in children with or suspected to have FAP starting at ages 10 to 12 years. We recommend follow-up colonoscopy for patients found to have rectosigmoid polyps if sigmoidoscopy was the initial screening test. In patients with negative sigmoidoscopy findings, colonoscopy screening should be offered starting in late teen years. (M)
324190
We recommend surveillance colonoscopy at 1- to 2-year intervals in FAP. (M)
324190
We recommend screening colonoscopy in patients with or suspected to have AFAP starting at ages 18 to 20 years. (L)
324190
We recommend surveillance colonoscopy at 1- to 2-year intervals in AFAP. (L)
324190
We recommend screening colonoscopy at ages 18 to 20 years in patients with or suspected to have MAP. (L)
324190
We recommend surveillance colonoscopy at 1- to 2-year intervals in MAP. (L)
324190
We recommend a pouch endoscopy or ileoscopy in patients with IPAA or ileostomy surgery at 1- to 2-year intervals. (VL)
324190
We recommend a sigmoidoscopy in patients with IRA surgery at 6-month to 1-year intervals indefinitely. (VL)
324190
We recommend upper GI surveillance based on the interval advised for the most severely affected organ, whether stomach or duodenum. (L)
324190
Surveillance examinations should include random biopsy sampling as well as targeted biopsy sampling of any suspicious lesions to assess for dysplasia and accurate duodenal Spigelman stage. Baseline Spigelman score ≥7 is associated with the development of duodenal HGD. (L)
324190
We recommend endoscopic resection of gastric and duodenal polyps >1 cm, given the risk of developing dysplasia. (L)
324190
We recommend endoscopic resection of all antral polyps, given the predominance of gastric adenomas in this location. (L)
324190
We recommend careful examination of the ampulla and periampullary region using a duodenoscope or cap-assisted gastroscope, given the predilection for cancer in this area. (L)
324190
We recommend biopsy sampling of the ampulla to assess for villous histology or dysplasia for only those with an identifiable mucosal abnormality, with care taken to avoid the pancreatic orifice because of the risk for pancreatitis. (L)
324190
We recommend the use of chemopreventive agents within the confines of a tertiary hereditary cancer center and/or as part of clinical trials, because data are still emerging regarding its clinical application in hereditary polyposis syndromes. (VL)
324190
Title
Role of Endoscopy in Familial Adenomatous Polyposis Syndromes
Authoring Organization
American Society for Gastrointestinal Endoscopy
Publication Month/Year
March 10, 2020
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Outpatient, Radiology services
Intended Users
Epidemiology infection prevention, genetics, nurse, nurse practitioner, physician, physician assistant, radiology technologist
Scope
Diagnosis, Management, Prevention
Diseases/Conditions (MeSH)
D011125 - Adenomatous Polyposis Coli
Keywords
colorectal cancer, endoscopy, dysplasia, gastrointestinal, familial adenomatous polyposis
Source Citation
Yang J, Gurudu SR, Koptiuch C, Agrawal D, Buxbaum JL, Abbas Fehmi SM, Fishman DS, Khashab MA, Jamil LH, Jue TL, Law JK, Lee JK, Naveed M, Qumseya BJ, Sawhney MS, Thosani N, Wani SB, Samadder NJ. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020 May;91(5):963-982.e2. doi:10.1016/j.gie.2020.01.028. Epub 2020 Mar 10. PMID: 32169282.
Methodology
Number of Source Documents
172
Literature Search Start Date
January 1, 2005
Literature Search End Date
May 1, 2018